Abstract:PURPOSE:Mycobacterium tuberculosis is a serious public health problem affecting hundreds of millions of elderly people worldwide, which is difficult to be treated by traditional methods because of the peculiarity of skeletal system and liver damage caused by high-dose administration. In this research, a porous drug release system has been attempted to encapsulate rifampicin (RIF) into poly (ε-caprolactone) (PCL) microspheres to improve the efficacy and benefit of anti-tuberculosis drug in skeletal system. MATERIALS AND METHODS:The microspheres prepared by two different methods, oil-in-oil (o/o) emulsion solvent evaporation method and oil-in-water (o/w) method, were characterized in terms of morphology, size, encapsulation efficiency, drug distribution, degradation, and crystallinity. RESULTS:The microspheres exhibited a porous structure with evenly drug distribution prepared by o/o emulsion solvent evaporation method, and their diameter ranged from 50.54 to 57.34 μm. The encapsulation efficiency was up to 61.86% when drug-loading content was only 1.51%, and showed a little decrease with the drug-loading content increasing. In vitro release studies revealed that the drug release from porous microspheres was controlled by non-Fickian diffusion, and almost 80% of the RIF were completely released after 10 days. The results of RIF-loaded microspheres on the antibacterial activity against Staphylococcus aureus proved that the porous microspheres had strong antibacterial ability. In addition, the polymer crystallinity had prominent influence on the degradation rate of microspheres regardless of the morphology. CONCLUSION:It was an efficient way to entrap slightly water-soluble drug like RIF into PCL by o/o emulsion solvent evaporation method with uniform drug distribution. The RIF-loaded porous PCL microspheres showed the combination of good antimicrobial properties and excellent cytocompatibility, and it could generate gentle environment by PCL slow degradation.

Fabrication of ofloxacin/PLGA microsphere for bone tuberculosis therapy

Comparing Microspheres with Different Internal Phase of Polyelectrolyte As Local Drug Delivery System for Bone Tuberculosis Therapy.

Ofloxacin-Delivery System of A Polyanhydride and Polylactide Blend Used in the Treatment of Bone Infection

Hyaluronic Acid As an Internal Phase Additive to Obtain Ofloxacin/Plga Microsphere by Double Emulsion Method

Poly-D, L-lactide and levofloxacin-blended beads: A sustained local releasing system to treat osteomyelitis

Development of an Antibacterial Bone Graft by Immobilization of Levofloxacin Hydrochloride-Loaded Mesoporous Silica Microspheres on a Porous Scaffold Surface.

Formulation, antimicrobial and toxicity evaluation of bioceramic based ofloxacin loaded biodegradable microspheres for periodontal infection

Formulation and in vitro characterization of rifampicin-loaded porous poly (ε-caprolactone) microspheres for sustained skeletal delivery.

A Mesoporous Silicon/poly-(Dl-lactic-co-glycolic) Acid Microsphere for Long Time Anti-Tuberculosis Drug Delivery.

A Novel Antimicrobial Nano-Composite Porous Material for Bone Repair

Preparation, in Vitro Release and Antibacterial Activity Evaluation of Rifampicin and Moxifloxacin-Loaded Poly(d,l-Lactide-co-glycolide) Microspheres.

Preparation and Evaluation of Ofloxacin-Loaded Palmitic Acid Solid Lipid Nanoparticles

Levofloxacin loaded mesoporous silica microspheres/nano-hydroxyapatite/polyurethane composite scaffold for the treatment of chronic osteomyelitis with bone defects

Sodium fusidate-poly(D,L-lactide-co-glycolide) microspheres: preparation, characterisation and in vivo evaluation of their effectiveness in the treatment of chronic osteomyelitis

Exploration and Preparation of Ofloxacin Biphasic Tablets Via Semi-solid Extrusion Technology

Pulmonary Targeting of Levofloxacin Using Microsphere-Based Dry Powder Inhalation

Preparation Of Compound Ornidazole/Pefloxacin Plga Microspheres And Evaluation Of The Pharmacological Effect On Chronic Periodontitis

Functionalization of Multi-walled Carbon Nanotubes for Sustained-releasing Ofloxacin

Facile Fabrication of Composite Scaffolds for Long-Term Controlled Dual Drug Release

Design of Experiment (DoE) Approach for Developing Inhalable PLGA Microparticles Loaded with Clofazimine for Tuberculosis Treatment

Influences of Microparticle Internal Phase on Hydrophilic Drug Loading Efficiency and Releasing